Clinical trials
Phase 1/2 Diffuse Intrinsic Pontine Glioma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Terminated | 5 |
| Recruiting | 4 |
| Active, not recruiting | 3 |
| Not yet recruiting | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sabine Mueller, MD, PhD | 2 |
| Alaunos Therapeutics | 1 |
| Aminex Therapeutics, Inc. | 1 |
| Children's Hospital Medical Center, Cincinnati | 1 |
| Children's Oncology Group | 1 |
| Eli Lilly and Company | 1 |
| GlaxoSmithKline | 1 |
| Hospital Infantil Universitario Niño Jesús, Madrid, Spain | 1 |
| Julie Krystal | 1 |
| M.D. Anderson Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diffuse Intrinsic Pontine Glioma | 22 |
| Glioma | 11 |
| Glioblastoma | 7 |
| Astrocytoma | 5 |
| Ependymoma | 4 |
| Medulloblastoma | 4 |
| Recurrence | 4 |
| Osteosarcoma | 3 |
| Brain Neoplasms | 2 |
| Central Nervous System Neoplasms | 2 |
Trials
Showing 51 to 22 of 22. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.